These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 12127599)

  • 1. The increased activity of plasma manganese superoxide dismutase in tardive dyskinesia is unrelated to the Ala-9Val polymorphism.
    Zhang Z; Zhang X; Hou G; Sha W; Reynolds GP
    J Psychiatr Res; 2002; 36(5):317-24. PubMed ID: 12127599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Manganese superoxide dismutase (MnSOD: Ala-9Val) gene polymorphism may not be associated with schizophrenia and tardive dyskinesia.
    Pae CU; Kim TS; Patkar AA; Kim JJ; Lee CU; Lee SJ; Jun TY; Lee C; Paik IH
    Psychiatry Res; 2007 Sep; 153(1):77-81. PubMed ID: 17582511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of the manganese superoxide dismutase gene Ala-9Val polymorphism with clinical phenotypes and tardive dyskinesia in schizophrenic patients.
    Liu H; Wang C; Chen PH; Zhang BS; Zheng YL; Zhang CX; Meng HQ; Wang Y; Chen DC; Xiu MH; Kosten TR; Zhang XY
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 May; 34(4):692-6. PubMed ID: 20346996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Manganese superoxide dismutase gene (MnSOD) polimorphism in schizophrenics with tardive dyskinesia from central Poland].
    Gałecki P; Pietras T; Szemraj J
    Psychiatr Pol; 2006; 40(5):937-48. PubMed ID: 17217237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Meta-Analyses of Manganese Superoxide Dismutase Activity, Gene Ala-9Val Polymorphism, and the Risk of Schizophrenia.
    Wang DF; Cao B; Xu MY; Liu YQ; Yan LL; Liu R; Wang JY; Lu QB
    Medicine (Baltimore); 2015 Sep; 94(36):e1507. PubMed ID: 26356721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pharmacogenetic assessment of antipsychotic-induced tardive dyskinesia: contribution of 5-hydroxytryptamine 2C receptor gene and of a combination of dopamine D3 variant allele (Gly) and MnSOD wild allele (Val)].
    Zhang Z; Hou G; Zhang X; Yao H; Sha W; Zhang X
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Apr; 20(2):98-102. PubMed ID: 12673575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Additive effect between quinine oxidoreductase gene (NQO1: Pro187Ser) and manganese superoxide dismutase gene (MnSOD: Ala-9Val) polymorphisms on tardive dyskinesia in patients with schizophrenia.
    Pae CU
    Psychiatry Res; 2008 Dec; 161(3):336-8. PubMed ID: 18977034
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Wang D; Tian Y; Chen J; Zhu R; Li J; Zhou H; Chen D; Wang L; Kosten TR; Zhang XY
    Curr Neuropharmacol; 2024; 22(14):2443-2452. PubMed ID: 38919004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Manganese superoxide dismutase gene polymorphism and schizophrenia: relation to tardive dyskinesia.
    Hori H; Ohmori O; Shinkai T; Kojima H; Okano C; Suzuki T; Nakamura J
    Neuropsychopharmacology; 2000 Aug; 23(2):170-7. PubMed ID: 10882843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood superoxide dismutase level in schizophrenic patients with tardive dyskinesia: association with dyskinetic movements.
    Zhang XY; Zhou DF; Cao LY; Chen DC; Zhu FY; Wu GY
    Schizophr Res; 2003 Aug; 62(3):245-50. PubMed ID: 12837521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between the MnSOD Ala-9Val polymorphism and development of schizophrenia and abnormal involuntary movements in the Xhosa population.
    Hitzeroth A; Niehaus DJ; Koen L; Botes WC; Deleuze JF; Warnich L
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Apr; 31(3):664-72. PubMed ID: 17291655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Manganese superoxide dismutase gene Ala-9Val polymorphism might be related to the severity of abnormal involuntary movements in Korean schizophrenic patients.
    Kang SG; Choi JE; An H; Park YM; Lee HJ; Han C; Kim YK; Kim SH; Cho SN; Joe SH; Jung IK; Kim L; Lee MS
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Dec; 32(8):1844-7. PubMed ID: 18790709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive function, plasma MnSOD activity, and MnSOD Ala-9Val polymorphism in patients with schizophrenia and normal controls.
    Zhang XY; Chen DC; Xiu MH; Yang FD; Tan Y; Luo X; Zuo L; Kosten TA; Kosten TR
    Schizophr Bull; 2014 May; 40(3):592-601. PubMed ID: 23588476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of CYP2D6 and CYP1A2 gene polymorphism with tardive dyskinesia in Chinese schizophrenic patients.
    Fu Y; Fan CH; Deng HH; Hu SH; Lv DP; Li LH; Wang JJ; Lu XQ
    Acta Pharmacol Sin; 2006 Mar; 27(3):328-32. PubMed ID: 16490169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between Ala-9Val polymorphism of Mn-SOD gene and schizophrenia.
    Akyol O; Yanik M; Elyas H; Namli M; Canatan H; Akin H; Yuce H; Yilmaz HR; Tutkun H; Sogut S; Herken H; Ozyurt H; Savas HA; Zoroglu SS
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jan; 29(1):123-31. PubMed ID: 15610954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Functional polymorphism of manganese superoxide dismutase (MnSOD) gene correlates with schizophrenia in Polish population].
    Gałecki P; Pietras T; Szemraj J; Florkowska K; Florkowski A; Zboralski K
    Pol Merkur Lekarski; 2006 Mar; 20(117):329-32. PubMed ID: 16780268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction between polymorphisms of the dopamine D3 receptor and manganese superoxide dismutase genes in susceptibility to tardive dyskinesia.
    Zhang ZJ; Zhang XB; Hou G; Yao H; Reynolds GP
    Psychiatr Genet; 2003 Sep; 13(3):187-92. PubMed ID: 12960753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low superoxide dismutase activity in schizophrenic patients with tardive dyskinesia.
    Yamada K; Kanba S; Anamizu S; Ohnishi K; Ashikari I; Yagi G; Asai M
    Psychol Med; 1997 Sep; 27(5):1223-5. PubMed ID: 9300527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Relationship between tardive dyskinesia and the polymorphism of superoxide dismutase val9Ala and efficacy of Chaihu Taoren Capsules on it].
    Su JM; Tan YL; Zhou DF
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2007 Aug; 27(8):700-3. PubMed ID: 17879532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CYP2D6 polymorphism and tardive dyskinesia in schizophrenic patients.
    Lohmann PL; Bagli M; Krauss H; Müller DJ; Schulze TG; Fangerau H; Ludwig M; Barkow K; Held T; Heun R; Maier W; Rietschel M; Rao ML
    Pharmacopsychiatry; 2003; 36(2):73-8. PubMed ID: 12734765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.